Avinainder Singh, MD, MMSc

• Adrian Haimovich
• Akiko Iwasaki
• Albert Ko
• Allen Hsiao
• Bobak Jack Mortazavi
• Chad Gier
• Charles Dela Cruz
• Charles Torre
• Eric Velazquez
• Frederick Warner
• Harlan Krumholz
• Jakob Park
• James V. Freeman
• Judith Meadows
• Justin Pacor
• Khurram Nasir
• Kim Germaine Emiel Smolderen
• Manan Pareek
• Maxwell Eder
• Merceditas Villanueva
• Murat Gunel
• Nihar Desai
• Rachel Lampert
• Richard Taylor
• Roozbeh Nikooie
• Roy S. Herbst
• Shelli Farhadian
• Tariq Ahmad
• Thomas Durant
• Wade Schulz
• Zain Ahmed
• Zaniar Ghazizadeh

Amyloidosis; Cardiomyopathy, Restrictive; Clinical Trials as Topic; Data Display; Data Interpretation, Statistical; Myocardial Infarction; Physical Examination; Research Design; Sarcoidosis; Acute Coronary Syndrome; Cardiac Imaging Techniques

• Statin therapy for young adults: A long-term investment worth considering.Miedema MD, Nauffal VD, Singh A, Blankstein R. Statin therapy for young adults: A long-term investment worth considering. Trends In Cardiovascular Medicine 2020, 30:48-53.
• Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry.Divakaran S, Singh A, Biery D, Yang J, DeFilippis EM, Collins BL, Ramsis M, Qamar A, Hainer J, Klein J, Cannon CP, Polk DM, Plutzky J, Nasir K, Januzzi JL, Di Carli MF, Bhatt DL, Blankstein R. Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry. Diabetes Care 2020, 43:1843-1850.
• Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults.Singh A, Gupta A, DeFilippis EM, Qamar A, Biery DW, Almarzooq Z, Collins B, Fatima A, Jackson C, Galazka P, Ramsis M, Pipilas DC, Divakaran S, Cawley M, Hainer J, Klein J, Jarolim P, Nasir K, Januzzi JL, Di Carli MF, Bhatt DL, Blankstein R. Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults. Journal Of The American College Of Cardiology 2020, 75:1003-1013.
• Application of the GRACE, TIMI, and TARRACO Risk Scores in Type 2 Myocardial Infarction.Murphy S, McCarthy C, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Cui J, Januzzi JL, Wasfy JH. Application of the GRACE, TIMI, and TARRACO Risk Scores in Type 2 Myocardial Infarction. Journal Of The American College Of Cardiology 2020, 75:344-345.
• Geographic variation in public interest about amyloidosis in the United States and English speaking countries.Vuong J, Singh A, Falk RH, Merchant R, Dorbala S. Geographic variation in public interest about amyloidosis in the United States and English speaking countries. Amyloid : The International Journal Of Experimental And Clinical Investigation : The Official Journal Of The International Society Of Amyloidosis 2020, 27:210-212.
• Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk.Vaduganathan M, Singh A, Sharma A, Januzzi JL, Scirica BM, Butler J, Zannad F, McGuire DK, Cannon CP, Bhatt DL. Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk. The American Journal Of Cardiology 2020, 125:1577-1581.
• Home-Time After Discharge Among Patients With Type 2 Myocardial Infarction.McCarthy CP, Murphy S, Rehman S, Jones-O'Connor M, Olshan DS, Cohen JA, Cui J, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Home-Time After Discharge Among Patients With Type 2 Myocardial Infarction. Journal Of The American Heart Association 2020, 9:e015978.
• Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry.Berman AN, Biery DW, Singh A, Wu WY, Divakaran S, DeFilippis EM, Hainer J, Blaha MJ, Cannon C, Polk DM, Plutzky J, Natarajan P, Nasir K, Carli MFD, Bhatt DL, Blankstein R. Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry. European Journal Of Preventive Cardiology 2020, 2047487320931296.
• Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.Singh A, Gupta A, Collins BL, Qamar A, Monda KL, Biery D, Lopez JAG, de Ferranti SD, Plutzky J, Cannon CP, Januzzi JL, Di Carli MF, Nasir K, Bhatt DL, Blankstein R. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. Journal Of The American College Of Cardiology 2019, 73:2439-2450.
• Mortality From Heart Failure and Dementia in the United States: CDC WONDER 1999-2016.Vuong JT, Jacob SA, Alexander KM, Singh A, Liao R, Desai AS, Dorbala S. Mortality From Heart Failure and Dementia in the United States: CDC WONDER 1999-2016. Journal Of Cardiac Failure 2019, 25:125-129.
• High sensitivity M-protein detection in a case of light-chain cardiac amyloidosis without evidence of plasma cell dyscrasia.Saadalla AM, Singh A, Barnidge D, Kohlhagen M, Merlini G, Falk RH, Murray D. High sensitivity M-protein detection in a case of light-chain cardiac amyloidosis without evidence of plasma cell dyscrasia. American Journal Of Hematology 2019, 94:619-621.
• Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes.McCarthy CP, Murphy S, Venkateswaran RV, Singh A, Chang LL, Joice MG, Rivero JM, Vaduganathan M, Januzzi JL, Bhatt DL. Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes. Journal Of The American College Of Cardiology 2019, 73:2007-2009.
• Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction.McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction. Journal Of The American College Of Cardiology 2019, 73:2005-2007.
• Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs.McCarthy C, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs. JAMA Cardiology 2019, 4:460-464.
• Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.Vaduganathan M, Patel RB, Singh A, McCarthy CP, Qamar A, Januzzi JL, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists. Journal Of The American College Of Cardiology 2019, 73:1596-1598.
• Response by DeFilippis et al to Letter Regarding Article, "Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction: Partners YOUNG-MI Registry".DeFilippis EM, Singh A, Bhatt DL, Blankstein R. Response by DeFilippis et al to Letter Regarding Article, "Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction: Partners YOUNG-MI Registry". Circulation 2019, 139:e996.
• Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction.McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction. Journal Of The American College Of Cardiology 2019, 73:3230-3232.
• Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria.Divakaran S, Singh A, DeFilippis EM, Churchill TW, Cuddy S, Ge Y, Ip IK, Zhou W, Skali H, Taqueti VR, Dorbala S, Spalding J, Xu Y, Khorasani R, Di Carli MF, Yialamas MA, Blankstein R. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2019.
• Causes of Troponin Elevation and Associated Mortality in Young Patients.Wu C, Singh A, Collins B, Fatima A, Qamar A, Gupta A, Hainer J, Klein J, Jarolim P, Di Carli M, Nasir K, Bhatt DL, Blankstein R. Causes of Troponin Elevation and Associated Mortality in Young Patients. The American Journal Of Medicine 2018, 131:284-292.e1.
• Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.Singh A, Collins BL, Gupta A, Fatima A, Qamar A, Biery D, Baez J, Cawley M, Klein J, Hainer J, Plutzky J, Cannon CP, Nasir K, Di Carli MF, Bhatt DL, Blankstein R. Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. Journal Of The American College Of Cardiology 2018, 71:292-302.
• Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction.DeFilippis EM, Singh A, Divakaran S, Gupta A, Collins BL, Biery D, Qamar A, Fatima A, Ramsis M, Pipilas D, Rajabi R, Eng M, Hainer J, Klein J, Januzzi JL, Nasir K, Di Carli MF, Bhatt DL, Blankstein R. Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction. Journal Of The American College Of Cardiology 2018, 71:2540-2551.
• Reply: Cardiovascular Risk Models and Statin Therapy.Singh A, DiCarli MF, Nasir K, Bhatt DL, Blankstein R. Reply: Cardiovascular Risk Models and Statin Therapy. Journal Of The American College Of Cardiology 2018, 71:2491-2492.
• 'A new staging system for cardiac transthyretin amyloidosis': is it already on the verge of obsolescence?Singh A, Falk RH. 'A new staging system for cardiac transthyretin amyloidosis': is it already on the verge of obsolescence? European Heart Journal 2018, 39:2807-2809.
• True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis.Singh A, Geller HI, Alexander KM, Padera RF, Mitchell RN, Dorbala S, Castillo JJ, Falk RH. True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis. Haematologica 2018, 103:e374-e376.
• Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction.DeFilippis EM, Singh A, Gupta A, Ayuba G, Biery D, Divakaran S, Collins BL, Qamar A, Fatima A, Hainer J, Klein J, Nasir K, Di Carli MF, Bhatt DL, Blankstein R. Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction. Circulation 2018, 138:2855-2857.
• Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis.Alexander KM, Orav J, Singh A, Jacob SA, Menon A, Padera RF, Kijewski MF, Liao R, Di Carli MF, Laubach JP, Falk RH, Dorbala S. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis. JAMA Cardiology 2018, 3:865-870.
• Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program.McCarthy CP, Vaduganathan M, Singh A, Song Z, Blankstein R, Gaggin HK, Wasfy JH, Januzzi JL. Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. Journal Of The American College Of Cardiology 2018, 72:1166-1170.
• Reply: Cocaine, Tobacco, and Toxicology in Myocardial Infarction of the Young.DeFilippis EM, Singh A, Bhatt DL, Blankstein R. Reply: Cocaine, Tobacco, and Toxicology in Myocardial Infarction of the Young. Journal Of The American College Of Cardiology 2018, 72:1561-1562.
• Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling.Vaduganathan M, Sathiyakumar V, Singh A, McCarthy CP, Qamar A, Januzzi JL, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling. Journal Of The American College Of Cardiology 2018, 72:3370-3372.
• Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis.Geller HI, Singh A, Mirto TM, Padera R, Mitchell R, Laubach JP, Falk RH. Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis. Mayo Clinic Proceedings 2017, 92:1800-1805.
• Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry.Hulten EA, Bittencourt MS, Preston R, Singh A, Romagnolli C, Ghoshhajra B, Shah R, Abbasi S, Abbara S, Nasir K, Blaha M, Hoffmann U, Di Carli MF, Blankstein R. Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry. Cardiovascular Diabetology 2017, 16:14.
• Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry.Singh A, Collins B, Qamar A, Gupta A, Fatima A, Divakaran S, Klein J, Hainer J, Jarolim P, Shah RV, Nasir K, Di Carli MF, Bhatt DL, Blankstein R. Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry. Clinical Cardiology 2017, 40:955-961.
• Role of Imaging in Evaluating Infiltrative Heart Disease.Divakaran S, Singh A, Collins B, Vita T, Falk RH, Di Carli MF, Blankstein R. Role of Imaging in Evaluating Infiltrative Heart Disease. Current Treatment Options In Cardiovascular Medicine 2017, 19:3.
• Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis.Singh A, Geller HI, Falk RH. Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. Journal Of The American College Of Cardiology 2017, 69:757-758.
• Enhanced Education for Noninvasive Cardiac Testing.Singh A, Divakaran S, Blankstein R. Enhanced Education for Noninvasive Cardiac Testing. JAMA Internal Medicine 2017, 177:746.
• Novel pharmacotherapies for cardiac amyloidosis.Alexander KM, Singh A, Falk RH. Novel pharmacotherapies for cardiac amyloidosis. Pharmacology & Therapeutics 2017, 180:129-138.
• Transthoracic Echocardiography to Assess Aortic Regurgitation after TAVR: A Comparison with Periprocedural Transesophageal Echocardiography.Goncalves A, Nyman C, Okada DR, Singh A, Swanson J, Cheezum M, Steigner M, Di Carli M, Solomon S, Shah PB, Bhatt DL, Shook D, Blankstein R. Transthoracic Echocardiography to Assess Aortic Regurgitation after TAVR: A Comparison with Periprocedural Transesophageal Echocardiography. Cardiology 2017, 137:1-8.
• Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis.Geller HI, Singh A, Alexander KM, Mirto TM, Falk RH. Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis. JAMA 2017, 318:962-963.
• Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol.Hulten E, Bittencourt MS, Singh A, O'Leary D, Christman MP, Osmani W, Abbara S, Steigner ML, Truong QA, Nasir K, Rybicki FF, Klein J, Hainer J, Brady TJ, Hoffmann U, Ghoshhajra BB, Hachamovitch R, Di Carli MF, Blankstein R. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol. Circulation. Cardiovascular Imaging 2014, 7:629-38.
• Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, Hainer J, Murthy VL, Skali H, Dorbala S, Di Carli MF, Blankstein R. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2014, 21:166-74.
• Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection.McPadden J, Warner F, Young HP, Hurley NC, Pulk RA, Singh A, Durant TJ, Gong G, Desai N, Haimovich A, Taylor RA, Gunel M, Dela Cruz CS, Farhadian SF, Siner J, Villanueva M, Churchwell K, Hsiao A, Torre CJ, Velazquez EJ, Herbst RS, Iwasaki A, Ko AI, Mortazavi BJ, Krumholz HM, Schulz WL. Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection. MedRxiv : The Preprint Server For Health Sciences 2020.
• Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI Registry.Biery DW, Berman AN, Singh A, Divakaran S, DeFilippis EM, Collins BL, Gupta A, Fatima A, Qamar A, Klein J, Hainer J, Blaha MJ, Di Carli MF, Nasir K, Bhatt DL, Blankstein R. Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI Registry. JAMA Network Open 2020, 3:e209649.
• Cholesterol Guidelines: A Missed Opportunity for Young Adults?Blankstein R, Singh A. Cholesterol Guidelines: A Missed Opportunity for Young Adults? Journal Of The American College Of Cardiology 2020, 76:665-668.
• Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry.Berman AN, Biery DW, Ginder C, Hulme OL, Marcusa D, Leiva O, Wu WY, Singh A, Divakaran S, Hainer J, Turchin A, Januzzi JL, Natarajan P, Cannon CP, Di Carli MF, Bhatt DL, Blankstein R. Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry. Clinical Cardiology 2020, 43:1209-1215.
• Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry).Pareek M, Singh A, Vadlamani L, Eder M, Pacor J, Park J, Ghazizadeh Z, Heard A, Cruz-Solbes AS, Nikooie R, Gier C, Ahmed ZV, Freeman JV, Meadows J, Smolderen KGE, Lampert R, Velazquez EJ, Ahmad T, Desai NR. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry). The American Journal Of Cardiology 2021, 146:99-106.
• Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry.Yang J, Biery D, Singh A, Divakaran S, DeFilippis EM, Wu WY, Klein J, Hainer J, Ramsis M, Natarajan P, Januzzi JL, Nasir K, Bhatt DL, Di Carli MF, Blankstein R. Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry. The American Journal Of Medicine 2020, 133:605-612.e1.